KEAP1 and gestational diabetes: Western blot revealed that the levels of the Keap1 dimer were lower in GDM patients than in non-GDM patients (Fig. 5A) and lower in the GDM group than in the NC group, whereas inhibiting PGK1 with NG52 reversed this decrease (Fig. S6A).